Roswell Park Comprehensive Cancer Center | Strategic Alliance Partners

July 22, 2025

Doctors join cancer center with expertise in surgical and medical oncology, pathology, dermatology, anesthesia.

July 17, 2025

Research centers across New York State are collaborating to develop cell therapies for cancer to expand progress in the emerging field of cell therapy.

June 30, 2025

Renier Brentjens, MD, PhD, invited to address Damon Runyon Foundation, New York Academy of Sciences

June 23, 2025

Roswell Park Comprehensive Cancer Center has been added to Newsweek’s list of America’s Best Cancer Hospitals for 2025.

June 19, 2025

Cancer center's Chief Strategy Officer and Chair of Thoracic Surgery joins prestigious organization

June 16, 2025

Experts from Roswell Park shared findings on these topics at the 2025 ASCO Annual Meeting.

May 31, 2025

Francisco J. Hernandez-Ilizaliturri, MD, discusses the design of an observational study investigating immunologic changes with venetoclax in CLL.

May 30, 2025

Matthew Cortese, MD, MPH, discusses the next steps for the multiomic evaluation of venetoclax activity in chronic lymphocytic leukemia.

May 30, 2025

Faculty from Roswell Park Comprehensive Cancer Center are among the experts invited to share their research findings at the 2025 ASCO Annual Meeting.

May 19, 2025

Collaborative Roswell Park/Columbia research uncovers greater risk of relapse and complications, lower survival rates.

May 12, 2025

The ongoing phase 2B SURVIVE clinical trial of SurVaxM in glioblastoma will continue following an interim analysis of trial data.

May 12, 2025

Renier Brentjens, MD, PhD, discusses the current landscape of CAR T-cell agents in patients with solid tumors.

April 25, 2025

Matthew Cortese, MD, MPH, discusses the rationale for an analysis of the immunologic activity of venetoclax in patients with chronic lymphocytic leukemia.

April 24, 2025

Researchers from Roswell Park Comprehensive Cancer Center will report their latest findings to colleagues at the 2025 AACR Annual Meeting.

April 22, 2025

Eunice Wang, MD, provides an overview of currently available AML treatments and highlights the importance of mutational sequencing strategies.

April 14, 2025

Yeong “Christopher” Choi, PhD, MBA, discusses the importance of developing biomedical technologies for hematologic malignancies and other diseases.

April 10, 2025

Roswell Park Comprehensive Cancer Center achieved textbook outcomes for 90% of 150 robot-assisted minimally invasive esophagectomies from 2020-2024.

April 08, 2025

Sayan Chakraborty, PhD and team focus on targeting agrin, a protein that promotes treatment resistance/relapse.

April 03, 2025

Marco Davila, MD, PhD, discusses how a study of tumor drivers of CAR T-cell therapy resistance in LBCL may promote future biomarker investigations.

April 03, 2025

Roswell Park-led study takes a significant step toward relief without opioid.